The CEO highlighted results from the REMAIN-1 Midpoint Cohort, where "Revita-treated patients lost an additional 2.5% of total body weight, while patients in the sham group regained about 10%, a ...
Clinical Data—SIMPLIFY Study -- Updated analysis increased Gallery's PPV in symptomatic patients to 84.2% after long-term ...
A pulse of light sets the tempo in the material. Atoms in a crystalline sheet just a few atoms thick begin to move—not ...
The creation of green polymer composites from waste materials offers a practical solution to construction challenges and ...
GIJC25 speaker Lina Ejeilat co-launched 7iber as a blog in 2007 and it has grown into an award-winning investigative site ...
In this excerpt from the new book 'Speak Data,' the Wharton professor and best-selling author shares his thoughts on how we ...
Temperature records from measurements of oxygen isotopes in the ice reveal that this area experienced a gradual, long-term ...
Q3 2025 Earnings Call November 12, 2025 4:30 PM ESTCompany ParticipantsBrian Luque - Head of Investor Relations & ...
VANCOUVER, BC / ACCESS Newswire / November 11, 2025 / (TSX:NANO)(OTCQB:NNOMF)(Frankfurt:LBMB) Business Operational Highlights Newly installed proprietary agitator in full-scale One-Pot™ reactor at ...
PolyPid Ltd. (NASDAQ: PYPD) Q3 2025 Earnings Call Transcript November 12, 2025 PolyPid Ltd. beats earnings expectations.
Jasper plans to report final conclusions from the investigation in the fourth quarter of 2025, supported by a key opinion leader panel that will review findings and provide clinical and chemistry, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback